Liberty Mutual Group Asset Management Has Cut By $426,948 Its West Pharmaceutical Svsc (WST) Position; ePlus Inc. (PLUS) Had 1 Bulls

November 14, 2017 - By Clifton Ray

Liberty Mutual Group Asset Management Inc decreased West Pharmaceutical Svsc Inc (WST) stake by 13.72% reported in 2017Q2 SEC filing. Liberty Mutual Group Asset Management Inc sold 4,542 shares as West

Pharmaceutical Svsc Inc (WST)’s stock rose 14.65%. The Liberty Mutual Group Asset Management Inc holds 28,563 shares with $2.70 million value, down from 33,105 last quarter. West Pharmaceutical Svsc Inc now has $7.49B valuation. The stock decreased 0.81% or $0.82 on November 14, reaching $100.85. About 281,182 shares traded. West Pharmaceutical Services Inc. (NYSE:WST) has risen 33.75% since November 14, 2016 and is uptrending. It has outperformed by 17.05% the S&P500.

Among 3 analysts covering ePlus (NASDAQ:PLUS), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. ePlus had 14 analyst reports since August 7, 2015 according to SRatingsIntel. Stifel Nicolaus maintained the stock with “Hold” rating in Sunday, September 10 report. Canaccord Genuity maintained the shares of PLUS in report on Thursday, November 5 with “Buy” rating. The rating was maintained by Stifel Nicolaus with “Hold” on Sunday, October 15. The company was downgraded on Friday, October 30 by Stifel Nicolaus. Sidoti downgraded ePlus Inc. (NASDAQ:PLUS) on Tuesday, November 15 to “Neutral” rating. The firm has “Hold” rating given on Thursday, August 3 by Stifel Nicolaus. The rating was downgraded by Sidoti on Friday, October 9 to “Neutral”. Sidoti downgraded it to “Neutral” rating and $91 target in Monday, October 12 report. The firm has “Hold” rating by Stifel Nicolaus given on Thursday, November 2. Zacks upgraded ePlus Inc. (NASDAQ:PLUS) on Friday, August 7 to “Sell” rating. See ePlus Inc. (NASDAQ:PLUS) latest ratings:

02/11/2017 Broker: Stifel Nicolaus Rating: Hold New Target: $80.0 Maintain
15/10/2017 Broker: Stifel Nicolaus Rating: Hold New Target: $75.0 Maintain
10/09/2017 Broker: Stifel Nicolaus Rating: Hold New Target: $75.0 Maintain
03/08/2017 Broker: Stifel Nicolaus Rating: Hold New Target: $75.0000 Maintain

Liberty Mutual Group Asset Management Inc increased Dst Sys Inc Del (NYSE:DST) stake by 21,624 shares to 35,786 valued at $2.21 million in 2017Q2. It also upped Kraft Heinz Co stake by 5,398 shares and now owns 38,497 shares. General Mls Inc (NYSE:GIS) was raised too.

Investors sentiment increased to 1.61 in Q2 2017. Its up 0.35, from 1.26 in 2017Q1. It improved, as 23 investors sold WST shares while 76 reduced holdings. 44 funds opened positions while 115 raised stakes. 67.09 million shares or 1.84% more from 65.87 million shares in 2017Q1 were reported. First Quadrant Lp Ca has invested 0.53% in West Pharmaceutical Services Inc. (NYSE:WST). Sterling Cap Ltd Llc owns 327,300 shares. Weaver C Barksdale Associates holds 0.01% in West Pharmaceutical Services Inc. (NYSE:WST) or 84 shares. Chatham Capital Group has 0.45% invested in West Pharmaceutical Services Inc. (NYSE:WST) for 17,300 shares. Susquehanna Int Llp has invested 0% in West Pharmaceutical Services Inc. (NYSE:WST). 60,932 are held by Loomis Sayles & Company Limited Partnership. Moreover, Ami Asset Mngmt has 1.68% invested in West Pharmaceutical Services Inc. (NYSE:WST) for 248,534 shares. Profund Advsr Llc holds 9,159 shares or 0.04% of its portfolio. Florida-based Voloridge Invest Management Ltd Liability Co has invested 0.14% in West Pharmaceutical Services Inc. (NYSE:WST). Spark Inv Ltd accumulated 30,800 shares or 0.18% of the stock. Aqr Cap Management Ltd Limited Liability Company invested in 318,920 shares. California Public Employees Retirement Systems holds 0.03% of its portfolio in West Pharmaceutical Services Inc. (NYSE:WST) for 169,300 shares. Ny State Teachers Retirement System holds 127,970 shares. Select Equity LP stated it has 3.14 million shares or 0% of all its holdings. Globeflex Capital LP invested in 0% or 10 shares.

Among 5 analysts covering West Pharmaceutical Services (NYSE:WST), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. West Pharmaceutical Services had 13 analyst reports since August 4, 2015 according to SRatingsIntel. Bank of America downgraded West Pharmaceutical Services Inc. (NYSE:WST) on Tuesday, October 17 to “Hold” rating. The stock of West Pharmaceutical Services Inc. (NYSE:WST) earned “Outperform” rating by Wells Fargo on Friday, October 28. Jefferies maintained West Pharmaceutical Services Inc. (NYSE:WST) on Tuesday, June 6 with “Hold” rating. The firm has “Hold” rating given on Tuesday, August 4 by Zacks. The firm has “Outperform” rating given on Friday, October 27 by Wells Fargo. Jefferies maintained it with “Hold” rating and $9600 target in Thursday, July 27 report. Jefferies upgraded West Pharmaceutical Services Inc. (NYSE:WST) on Friday, September 15 to “Buy” rating. The firm has “Buy” rating by Janney Capital given on Friday, January 8. The rating was maintained by Jefferies with “Hold” on Monday, September 11. The stock of West Pharmaceutical Services Inc. (NYSE:WST) has “Hold” rating given on Thursday, June 29 by Jefferies.

Analysts await West Pharmaceutical Services Inc. (NYSE:WST) to report earnings on February, 15. They expect $0.61 EPS, up 12.96% or $0.07 from last year’s $0.54 per share. WST’s profit will be $45.30 million for 41.33 P/E if the $0.61 EPS becomes a reality. After $0.67 actual EPS reported by West Pharmaceutical Services Inc. for the previous quarter, Wall Street now forecasts -8.96% negative EPS growth.

Investors sentiment increased to 4.68 in Q2 2017. Its up 2.90, from 1.78 in 2017Q1. It improved, as 18 investors sold ePlus Inc. shares while 13 reduced holdings. 35 funds opened positions while 110 raised stakes. 23.51 million shares or 266.01% more from 6.42 million shares in 2017Q1 were reported. Royal Bankshares Of Canada holds 0% or 23,677 shares in its portfolio. Thomson Horstmann Bryant Inc invested in 1.59% or 166,180 shares. Matarin Capital Mngmt Lc accumulated 0% or 98,109 shares. Thrivent For Lutherans has invested 0% in ePlus Inc. (NASDAQ:PLUS). Legal And General Gru Public Ltd Co holds 0% of its portfolio in ePlus Inc. (NASDAQ:PLUS) for 23,736 shares. Camarda Fincl Advsrs Limited Liability Corporation holds 1.99% of its portfolio in ePlus Inc. (NASDAQ:PLUS) for 25,105 shares. Credit Suisse Ag reported 0% stake. The Pennsylvania-based Sei Invs has invested 0% in ePlus Inc. (NASDAQ:PLUS). Moreover, Clarivest Asset Management Limited Liability Com has 0.04% invested in ePlus Inc. (NASDAQ:PLUS) for 20,998 shares. Ameritas Investment Inc holds 0% in ePlus Inc. (NASDAQ:PLUS) or 1,064 shares. Laurion Capital Management L P invested in 0% or 5,600 shares. Martingale Asset Mgmt Limited Partnership has 0.04% invested in ePlus Inc. (NASDAQ:PLUS). 3,234 are owned by Ubs Asset Americas. Financial Bank Of Montreal Can, a Ontario – Canada-based fund reported 1,606 shares. Jacobs Levy Equity Incorporated reported 0.01% stake.

The stock decreased 0.58% or $0.45 during the last trading session, reaching $76.95. About 86,155 shares traded. ePlus Inc. (NASDAQ:PLUS) has risen 75.66% since November 14, 2016 and is uptrending. It has outperformed by 58.96% the S&P500.

Since May 30, 2017, it had 0 insider purchases, and 5 selling transactions for $5.53 million activity. $272,125 worth of ePlus Inc. (NASDAQ:PLUS) was sold by HOVDE ERIC D. The insider Marion Elaine D sold $392,956. NORTON PHILLIP G had sold 20,880 shares worth $1.65 million on Thursday, June 8.

ePlus inc. is a holding company. The Company is engaged in the business of selling, leasing, financing and managing information technology. The company has market cap of $1.09 billion. It operates through two divisions: technology and financing. It has a 20.03 P/E ratio. The technology segment sells information technology hardware products, third-party software and maintenance contracts, its own and third-party professional and managed services, and its software.

By

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>